Industry Strength Score
11/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
LEXAGENE HOLDINGS INC (LXG.CA) Stock Price & Overview
TSX-V:LXG • CA52886L1031
Current stock price
0.105 CAD
-0.03 (-19.23%)
Last:
The current stock price of LXG.CA is 0.105 CAD. Today LXG.CA is down by -19.23%. In the past month the price decreased by -62.5%. In the past year, price decreased by -63.16%.
LXG.CA Key Statistics
52-Week Range0.065 - 0.3
Current LXG.CA stock price positioned within its 52-week range.
1-Month Range0.1 - 0.275
Current LXG.CA stock price positioned within its 1-month range.
- Market Cap
- 14.767M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.18
- Dividend Yield
- N/A
LXG.CA Stock Performance
Today
-19.23%
1 Week
-54.35%
1 Month
-62.50%
3 Months
-53.33%
Longer-term
6 Months -27.59%
1 Year -63.16%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A
LXG.CA Stock Chart
LXG.CA Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to LXG.CA. When comparing the yearly performance of all stocks, LXG.CA is a bad performer in the overall market: 97.7% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
LXG.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to LXG.CA. Both the profitability and financial health of LXG.CA have multiple concerns.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
LXG.CA Earnings
Next Earnings DateN/A
Last Earnings DateN/A
PeriodQ3 / 2023
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %
LXG.CA Forecast & Estimates
9 analysts have analysed LXG.CA and the average price target is 0.51 CAD. This implies a price increase of 385.71% is expected in the next year compared to the current price of 0.105.
Analysts
Analysts84.44
Price Target0.51 (385.71%)
EPS Next YN/A
Revenue Next YearN/A
LXG.CA Financial Highlights
Over the last trailing twelve months LXG.CA reported a non-GAAP Earnings per Share(EPS) of -0.18. The EPS decreased by -45.78% compared to the year before.
Income Statements
Revenue(TTM)194.46K
Net Income(TTM)-16.51M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0.44 |
Chartmill High Growth Momentum
EPS Q2Q%46.52%
Sales Q2Q%-11.18%
EPS 1Y (TTM)-45.78%
Revenue 1Y (TTM)32.22%
LXG.CA Ownership
Ownership
Inst Owners0%
Shares140.64M
Float120.87M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
LXG.CA Industry Overview
LXG.CA operates in the Health Care Equipment sub-industry within the Health Care sector. This group contains 127 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
61/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
17%
Outperformed 17% of sub-industries
3 Month Rank
12%
Outperformed 12% of sub-industries
6 Month Rank
10%
Outperformed 10% of sub-industries
Industry Fundamentals & Breadth
- Members
- 127
- New Highs
- 3.2%
- New Lows
- 13.4%
- Average ROE
- 17.1%
- Average Profit Margin
- 20.3%
- Average Operating Margin
- 22.5%
- Average P/E
- 28.4
- Average Fwd P/E
- 26.8
- Average Debt/Equity
- 0.5
LXG.CA Competitors/Peers
The largest stocks on the Canadian markets in the "Health Care Equipment" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| PRN | PROFOUND MEDICAL CORP | N/A | 333.238M | ||
| TLT | THERALASE TECHNOLOGIES INC | N/A | 82.259M | ||
| PINK | PERIMETER MEDICAL IMAGING AI | N/A | 45.892M | ||
| MIR | MEDMIRA INC | N/A | 41.707M | ||
| CNVI | CONAVI MEDICAL CORP | N/A | 40.361M | ||
| VPT | VENTRIPOINT DIAGNOSTICS LTD | N/A | 22.519M | ||
| ASG | AURORA SPINE CORP | N/A | 21.236M | ||
| NSCI | NANALYSIS SCIENTIFIC CORP | N/A | 20.075M | ||
| MDX | MEDX HEALTH CORP | N/A | 18.036M | ||
| THRM | THERMA BRIGHT INC | N/A | 3.125M | ||
| VER-H | VERISANTE TECHNOLOGY INC | N/A | 659.1K | ||
| VVTM | VVT MED INC | N/A |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the TSX Venture Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
About LXG.CA
Company Profile
Lexagene Holdings Inc. develops biomedical devices. The company is headquartered in Beverly, Massachusetts and currently employs 33 full-time employees. The company went IPO on 2007-08-28. The firm is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The firm's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.
Company Info
IPO: 2007-08-28
LEXAGENE HOLDINGS INC
500 Cummings Ctr., Suite 4550
Beverly MASSACHUSETTS 01915 US
CEO: John F. Regan
Employees: 33
Phone: 18002151824.0
LEXAGENE HOLDINGS INC / LXG.CA FAQ
What does LXG do?
Lexagene Holdings Inc. develops biomedical devices. The company is headquartered in Beverly, Massachusetts and currently employs 33 full-time employees. The company went IPO on 2007-08-28. The firm is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The firm's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.
What is the current price of LXG stock?
The current stock price of LXG.CA is 0.105 CAD. The price decreased by -19.23% in the last trading session.
Does LXG stock pay dividends?
LXG.CA does not pay a dividend.
How is the ChartMill rating for LEXAGENE HOLDINGS INC?
LXG.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Can you provide the sector and industry classification for LEXAGENE HOLDINGS INC?
LEXAGENE HOLDINGS INC (LXG.CA) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
Is LEXAGENE HOLDINGS INC (LXG.CA) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on LXG.CA.
Can you provide the number of employees for LEXAGENE HOLDINGS INC?
LEXAGENE HOLDINGS INC (LXG.CA) currently has 33 employees.